Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Parameter adaptations during phenotype transitions in progressive diseases.

Tiemann CA, Vanlier J, Hilbers PA, van Riel NA.

BMC Syst Biol. 2011 Oct 26;5:174. doi: 10.1186/1752-0509-5-174.

PMID:
22029623
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Parameter trajectory analysis to identify treatment effects of pharmacological interventions.

Tiemann CA, Vanlier J, Oosterveer MH, Groen AK, Hilbers PA, van Riel NA.

PLoS Comput Biol. 2013;9(8):e1003166. doi: 10.1371/journal.pcbi.1003166. Epub 2013 Aug 1.

PMID:
23935478
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Applications of analysis of dynamic adaptations in parameter trajectories.

van Riel NA, Tiemann CA, Vanlier J, Hilbers PA.

Interface Focus. 2013 Apr 6;3(2):20120084. doi: 10.1098/rsfs.2012.0084.

PMID:
23853705
[PubMed]
Free PMC Article
4.

Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease.

Bai Q, Zhang X, Xu L, Kakiyama G, Heuman D, Sanyal A, Pandak WM, Yin L, Xie W, Ren S.

Metabolism. 2012 Jun;61(6):836-45. doi: 10.1016/j.metabol.2011.11.014. Epub 2012 Jan 5.

PMID:
22225954
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.

Kim EJ, Yoon YS, Hong S, Son HY, Na TY, Lee MH, Kang HJ, Park J, Cho WJ, Kim SG, Koo SH, Park HG, Lee MO.

Hepatology. 2012 May;55(5):1379-88. doi: 10.1002/hep.25529. Erratum in: Hepatology. 2013 Jan;57(1):423.

PMID:
22183856
[PubMed - indexed for MEDLINE]
6.

Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.

Sheng X, Wang M, Lu M, Xi B, Sheng H, Zang YQ.

Am J Physiol Endocrinol Metab. 2011 May;300(5):E886-93. doi: 10.1152/ajpendo.00332.2010. Epub 2011 Mar 1.

PMID:
21364120
[PubMed - indexed for MEDLINE]
Free Article
7.

Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases.

Faulds MH, Zhao C, Dahlman-Wright K.

Curr Opin Pharmacol. 2010 Dec;10(6):692-7. doi: 10.1016/j.coph.2010.07.003. Epub 2010 Sep 9. Review.

PMID:
20829110
[PubMed - indexed for MEDLINE]
8.

Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.

Kay HY, Kim WD, Hwang SJ, Choi HS, Gilroy RK, Wan YJ, Kim SG.

Antioxid Redox Signal. 2011 Oct 15;15(8):2135-46. doi: 10.1089/ars.2010.3834. Epub 2011 Jun 13.

PMID:
21504366
[PubMed - indexed for MEDLINE]
9.

Estimating the size of the solution space of metabolic networks.

Braunstein A, Mulet R, Pagnani A.

BMC Bioinformatics. 2008 May 19;9:240. doi: 10.1186/1471-2105-9-240.

PMID:
18489757
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.

van Straten EM, van Meer H, Huijkman NC, van Dijk TH, Baller JF, Verkade HJ, Kuipers F, Plösch T.

Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1171-8. doi: 10.1152/ajpendo.00021.2009. Epub 2009 Sep 1.

PMID:
19724022
[PubMed - indexed for MEDLINE]
Free Article
11.

Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.

Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, Lee JH, Khadem S, Ren S, Li S, Silverstein RL, Xie W.

Gastroenterology. 2008 Feb;134(2):556-67. doi: 10.1053/j.gastro.2007.11.037. Epub 2007 Nov 28.

PMID:
18242221
[PubMed - indexed for MEDLINE]
12.

Liver X receptors bridge hepatic lipid metabolism and inflammation.

Liu Y, Qiu de K, Ma X.

J Dig Dis. 2012 Feb;13(2):69-74. doi: 10.1111/j.1751-2980.2011.00554.x. Review.

PMID:
22257474
[PubMed - indexed for MEDLINE]
13.

A hybrid model of anaerobic E. coli GJT001: combination of elementary flux modes and cybernetic variables.

Kim JI, Varner JD, Ramkrishna D.

Biotechnol Prog. 2008 Sep-Oct;24(5):993-1006. doi: 10.1002/btpr.73.

PMID:
19194908
[PubMed - indexed for MEDLINE]
14.

Mathematical formalisms based on approximated kinetic representations for modeling genetic and metabolic pathways.

Alves R, Vilaprinyo E, Hernádez-Bermejo B, Sorribas A.

Biotechnol Genet Eng Rev. 2008;25:1-40. Review.

PMID:
21412348
[PubMed - indexed for MEDLINE]
15.

Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.

van der Leij FR, Bloks VW, Grefhorst A, Hoekstra J, Gerding A, Kooi K, Gerbens F, te Meerman G, Kuipers F.

Genomics. 2007 Dec;90(6):680-9. Epub 2007 Oct 22.

PMID:
17933490
[PubMed - indexed for MEDLINE]
Free Article
16.

Continuous modeling of metabolic networks with gene regulation in yeast and in vivo determination of rate parameters.

Moisset P, Vaisman D, Cintolesi A, Urrutia J, Rapaport I, Andrews BA, Asenjo JA.

Biotechnol Bioeng. 2012 Sep;109(9):2325-39. doi: 10.1002/bit.24503. Epub 2012 Apr 24.

PMID:
22447363
[PubMed - indexed for MEDLINE]
17.

Alternative splicing in Acad8 resulting a mitochondrial defect and progressive hepatic steatosis in mice.

Sabbagha NG, Kao HJ, Yang CF, Huang CC, Lin WD, Tsai FJ, Chen TH, Tarn WY, Wu JY, Chen YT.

Pediatr Res. 2011 Jul;70(1):31-6. doi: 10.1038/pr.2011.256.

PMID:
21659959
[PubMed - indexed for MEDLINE]
18.

Metabolic fluxes and beyond-systems biology understanding and engineering of microbial metabolism.

Kohlstedt M, Becker J, Wittmann C.

Appl Microbiol Biotechnol. 2010 Nov;88(5):1065-75. doi: 10.1007/s00253-010-2854-2. Epub 2010 Sep 7. Review.

PMID:
20821203
[PubMed - indexed for MEDLINE]
19.

The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.

Oosterveer MH, Grefhorst A, Groen AK, Kuipers F.

Prog Lipid Res. 2010 Oct;49(4):343-52. doi: 10.1016/j.plipres.2010.03.002. Epub 2010 Apr 2. Review.

PMID:
20363253
[PubMed - indexed for MEDLINE]
20.

Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.

Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.

J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.

PMID:
21929649
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk